VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update

Core Viewpoint - VolitionRx Limited will host a conference call on March 31, 2025, to discuss its financial and operational results for Q4 and the full fiscal year 2024, along with a business update [1][2]. Group 1: Conference Call Details - The conference call is scheduled for March 31, 2025, at 4:30 p.m. U.S. Eastern Time [1][2]. - Dial-in numbers for the call include a toll-free option for the U.S. and Canada at 1-877-407-9716, and an international toll number at 1-201-493-6779 [2]. - The call will be hosted by key executives including the Group Chief Marketing & Communications Officer, the President and Group CEO, the Group CFO, and the Chief Medical Officer [2]. Group 2: Company Overview - Volition is a multinational company focused on advancing epigenetics to improve early detection and monitoring of diseases [4][5]. - The company is developing cost-effective blood tests for various diseases, including certain cancers and conditions related to NETosis, such as sepsis [5]. - Research and development activities are primarily based in Belgium, with additional facilities in the U.S. and London [5].